Visalytics
Visalytics
approved EB-2 (NIW)

Computational Biologist

Bioinformatics · China · 2022-04-27

Processing Time
96 days
Decision Date
2022-04-27
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing state-of-the-art analytical algorithms for identifying disease signature biomarkers. This work focuses on advancing early diagnosis and intervention strategies for cancer and other diseases, with a specific emphasis on aggressive kidney cancer subtypes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses kidney cancer, a leading cause of death in the U.S., and aims to reduce the significant financial burden of the disease on the national healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated success through 10 total publications, 80 citations, and receiving funding from major federal agencies like the NIH and NSF.

3 Balance of Interests Met

The petitioner's unique expertise in bioinformatics and his history of identifying novel cancer-related biomarkers make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 8 peer-reviewed journal articles, 2 conference papers, and 80 citations. Evidence included 4 expert recommendation letters, 3 peer-review assignments, and research funding from the National Science Foundation (NSF), National Institutes of Health (NIH), and National Cancer Institute (NCI).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 21 days 2023-03-15
The petitioner proposes to develop next-generation computer-based approaches and algorithms to guide drug discovery and development. This research focuses on providing essential tools and techniques for discerning and targeting key complexes in the diagnosis and treatment of major human diseases such as cancer and chronic kidney disease.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Director

Healthcare · Turkey

WeGreened EB-2 (NIW) approved
Georgia 6 days 2023-10-02
The petitioner proposes to continue her research in translational pathology, specifically examining biobank data to investigate underlying cancer mechanisms. Her work focuses on identifying novel biomarkers to improve diagnostics, treatments, and patient outcomes for various forms of cancer.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
California 612 days 2025-08-21
The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 96 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist